Literature DB >> 12653729

Causes, investigation and treatment of leg ulceration.

J R Mekkes1, M A M Loots, A C Van Der Wal, J D Bos.   

Abstract

Chronic ulceration of the lower leg is a frequent condition, with a prevalence of 3-5% in the population over 65 years of age. The incidence of ulceration is rising as a result of the ageing population and increased risk factors for atherosclerotic occlusion such as smoking, obesity and diabetes. Ulcers can be defined as wounds with a 'full thickness depth' and a 'slow healing tendency'. In general, the slow healing tendency is not simply explained by depth and size, but caused by an underlying pathogenetic factor that needs to be removed to induce healing. The main causes are venous valve insufficiency, lower extremity arterial disease and diabetes. Less frequent conditions are infection, vasculitis, skin malignancies and ulcerating skin diseases such as pyoderma gangrenosum. But even rarer conditions exist, such as the recently discovered combination of vasculitis and hypercoagulability. For a proper treatment of patients with leg ulcers, it is important to be aware of the large differential diagnosis of leg ulceration.

Entities:  

Mesh:

Year:  2003        PMID: 12653729     DOI: 10.1046/j.1365-2133.2003.05222.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  51 in total

1.  A prospective, multi-centre, randomised, open label, parallel, comparative study to evaluate effects of AQUACEL® Ag and Urgotul® Silver dressing on healing of chronic venous leg ulcers.

Authors:  Keith Harding; Finn Gottrup; Arkadiusz Jawień; Jacek Mikosiński; Krystyna Twardowska-Saucha; Sławomir Kaczmarek; Maciej Sopata; Cliff Shearman; Alaine Pieronne; Dheerendra Kommala
Journal:  Int Wound J       Date:  2011-11-09       Impact factor: 3.315

2.  [When is a wound chronic?].

Authors:  J Dissemond
Journal:  Hautarzt       Date:  2006-01       Impact factor: 0.751

Review 3.  [Modern wound dressings for the therapy of chronic wounds].

Authors:  J Dissemond
Journal:  Hautarzt       Date:  2006-10       Impact factor: 0.751

4.  Cost-effectiveness of using Polyheal compared with surgery in the management of chronic wounds with exposed bones and/or tendons due to trauma in France, Germany and the UK.

Authors:  Julian F Guest; Erikas Sladkevicius; Monica Panca
Journal:  Int Wound J       Date:  2013-03-13       Impact factor: 3.315

5.  Efficacy and cost-effectiveness of octenidine wound gel in the treatment of chronic venous leg ulcers in comparison to modern wound dressings.

Authors:  Gilbert Hämmerle; Robert Strohal
Journal:  Int Wound J       Date:  2014-03-03       Impact factor: 3.315

Review 6.  The role of adult tissue-derived stem cells in chronic leg ulcers: a systematic review focused on tissue regeneration medicine.

Authors:  Bruno Amato; Rita Compagna; Maurizio Amato; Lucia Butrico; Francesco Fugetto; Mariia D Chibireva; Andrea Barbetta; Marco Cannistrà; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2015-09-24       Impact factor: 3.315

7.  [Chronic leg ulcers in older patients].

Authors:  N Duschek; F Trautinger
Journal:  Z Gerontol Geriatr       Date:  2019-06-11       Impact factor: 1.281

8.  A large Italian observational multicentre study on vascular ulcers of the lower limbs (Studio Ulcere Vascolari).

Authors:  Alessandro Apollonio; Pier L Antignani; Michelangelo Di Salvo; Giacomo Failla; Giorgio Guarnera; Giovanni Mosti; Elia Ricci
Journal:  Int Wound J       Date:  2014-02-12       Impact factor: 3.315

Review 9.  The diagnosis of infection in chronic leg ulcers: A narrative review on clinical practice.

Authors:  Ut T Bui; Kathleen Finlayson; Helen Edwards
Journal:  Int Wound J       Date:  2019-01-29       Impact factor: 3.315

10.  Clinical efficacy of a silver-releasing foam dressing in venous leg ulcer healing: a randomised controlled trial.

Authors:  Patricia Senet; Renzo Bause; Bo Jørgensen; Karsten Fogh
Journal:  Int Wound J       Date:  2013-02-04       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.